A Prospective Trial of an Endoscopic Quality Improvement Project

Mayo Clinic10 enrolled

Overview

Randomized prospective multi-site validation study.

GI practice sites that have recently agreed to participate in the GIQuIC program will be randomized on a site-basis, to the EQUIP intervention or control. Baseline ADR and polyp/surveillance predication accuracy will be collected for approximately 3 months. Sites randomized to the EQUIP intervention will undergo face-to-face training by a study investigator, followed by active monitoring and feedback. Control sites will not receive supplemental training and will be monitored by with no feedback. After completion of the study all sites will be offered the intervention (as is standard feedback in GIQuIC ).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Enrollment

Conditions

Colon Polyps

Interventions

Educational TrainingOTHER

Intervention/Training offered to endoscopists only.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Endoscopy centers that are new to GIQuIC and have not yet received training * All endoscopists performing screening and surveillance colonoscopy at the participating center will be invited to participate Exclusion Criteria: * Cases that involve acute indications such as bleeding and active colitis will not be included in data pool * Patients with a family or personal history of a polyposis syndrome or with a personal history of inflammatory bowel disease will also be excluded * Procedures that are deemed incomplete will be excluded * Patients with surgically altered anatomy (i.e. prior colectomy) and with poor bowel preparation (Boston bowel preparation score \<5, or inadequate to exclude polyps \>5mm) will be excluded

Locations (1)

Mayo Clinic Florida

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

Change in adenoma detection rates.

The primary outcome will be the change in adenoma detection rates between baseline and the intervention. Validate the effect of a quality improvement training program on the proportion of patients among whom at least one adenoma is detected

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.